New Drug Delivery System Breaks The 'Mucus Barrier
[read article]
FEB 23, 2009
Chemical engineers from Johns Hopkins University have broken the "mucus barrier," engineering the first drug-delivery particles capable of passing through human mucus - regarded by many as nearly impenetrable - and carrying medication that could treat a range of diseases. Those conditions include lung cancer, cervical cancer and cystic fibrosis...[read article]
Cystic Fibrosis Axentis Pharma Initiates Clinical Trial For Lung Infections
[read article]
FEB 20, 2009
Axentis Pharma AG has initiated a clinical phase IIa trial to assess the safety and tolerability of a new therapeutic formulation for the treatment of severe pulmonary infection in cystic fibrosis patients. The new formulation allows an established therapeutic agent to be delivered directly to the site of infection ...[read article]
Protein Opens Hope Of Treatment For Cystic Fibrosis Patients
[read article]
FEB 17, 2009
Scientists have finally identified a direct role for the missing protein that leaves cystic fibrosis patients open to attack from lung-damaging bacteria, the main reason most of them die before their 35th birthday, scientists heard at the Society for General Microbiology's Autumn meeting being held this week at Trinity College, Dublin)...[read article]
Quicker, More Accurate Evaluation For Cystic Fibrosis Patients Promised By New Test
[read article]
FEB 15, 2009
IResearchers at National Jewish Health have identified a simple gene-based blood test that more accurately and quickly measures cystic fibrosis patients' response to therapy than current tests. The test, a measure of inflammatory gene expression..[read article]
Researchers Develop New Model For Cystic Fibrosis
[read article]
FEB 13, 2009
In a first, researchers at the University of Iowa and the University of Missouri (MU) have developed a pig model for cystic fibrosis (CF) that appears to closely mimic the disease in human infants. The striking similarities between disease manifestations in the CF piglets and human newborns with CF suggest that this new model will help ...[read article]
New Drug Hope For Cystic Fibrosis Patients
Speaking at the conference, Dr Sheppard said: ...
[read article]
FEB 11, 2009
A new drug therapy may represent a tremendous step forward in the treatment of some 70,000 cystic fibrosis (CF) patients worldwide, Dr David Sheppard from the University of Bristol told an audience at the BA Festival of Science in Liverpool. Speaking at the conference, Dr Sheppard said: ...
[read article]
Children With Cystic Fibrosis Not Well Covered By Guidelines For Vitamin D Needs
[read article]
FEB 09, 2009
Existing recommendations for treating vitamin D deficiency in children with cystic fibrosis (CF) are too low to cover the serious need, leaving most at high risk for bone loss and rickets, according to researchers at Johns Hopkins Children's Center...[read article]
Kamada Reports Positive Phase II Data With Inhaled AAT In Cystic Fibrosis
[read article]
FEB 07, 2009
Kamada (TASE:KMDA), a biopharmaceutical company engaged in the development, manufacturing and marketing of specialty life-saving therapeutics, announced today positive data from its Phase II study evaluating inhaled Alpha-1 Antitrypsin (AAT) delivered via an Investigational eFlow® Nebulizer System (PARI Pharma GmbH)....[read article]
Mpex Pharmaceuticals Presents New Data On MP-376 In Cystic Fibrosis
[read article]
FEB 1, 2009
Mpex Pharmaceuticals, Inc. announced additional clinical and preclinical results with MP-376, the company's novel formulation of levofloxacin inhaled solution delivered by an Investigational eFlow Nebulizer System for use in cystic fibrosis (CF) and chronic obstructive pulmonary disease (COPD). Clinical results show that aerosol dosing of MP-376 was well tolerated at all dose levels tested after 14 days of...[read article]
